Related Experiment Video
Updated: Jul 22, 2026
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
The Treat-to-Target Project in Atopic Dermatitis: One Year On
Marjolein De Bruin-Weller1, Mette Deleuran2, Tilo Biedermann3
1Department of Allergology and Dermatology, UMC Utrecht, National Expertise Center for Eczema, Utrecht, The Netherlands. m.s.debruin-weller@umcutrecht.nl.
Abstract:
Atopic dermatitis is a chronic skin condition for which a range of systemic treatments have recently been approved. A treat-to-target strategy has been developed previously alongside an algorithm to guide the management of patients with atopic dermatitis. Here, we review the strategy and algorithm in the context of the evolving therapeutic landscape, and identify areas for further refinement and development.
Insights
New systemic treatments for atopic dermatitis (AD) are available. This review examines the current treat-to-target strategy and management algorithm for AD, considering recent therapeutic advancements and suggesting areas for improvement.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis is a chronic inflammatory skin disease.
- Recent approvals of systemic treatments have expanded therapeutic options.
- A treat-to-target strategy and management algorithm previously guided AD care.
Purpose of the Study:
- To review the existing treat-to-target strategy and management algorithm for atopic dermatitis.
- To contextualize these guidelines within the evolving landscape of systemic therapies.
- To identify areas needing refinement and future development in AD management.
Main Methods:
- Literature review of recent systemic treatments for atopic dermatitis.
- Analysis of the current treat-to-target strategy and management algorithm.
- Synthesis of information to identify gaps and areas for improvement.
Main Results:
- The therapeutic landscape for atopic dermatitis has significantly evolved with new systemic agents.
- The existing strategy and algorithm require updates to incorporate these advancements.
- Specific areas for refinement in patient management have been identified.
Conclusions:
- The current treat-to-target strategy and algorithm for atopic dermatitis need adaptation.
- Integration of newly approved systemic treatments is crucial for optimal patient outcomes.
- Further research and guideline development are necessary to refine atopic dermatitis management.
